KORU Medical Systems (NASDAQ: KRMD) details preliminary 2025 results

Rhea-AI Filing Summary

KORU Medical Systems, Inc. reported that it has released a press release with certain preliminary financial results for the fiscal quarter and full year ended December 31, 2025. These figures are based on the company’s current estimates and may change after completion of its normal closing and review procedures. The details of the preliminary results are provided in the press release included as Exhibit 99.1. The company specifies that this information is being furnished rather than filed under securities laws, which affects how it is incorporated into other regulatory documents.

false 0000704440 0000704440 2026-01-12 2026-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)   January 12, 2026

KORU Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

Delaware	0-12305	13-3044880
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

100 Corporate Drive, Mahwah, NJ	07430
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code   (845) 469-2042

______________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
common stock, $0.01 par value	KRMD	The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

(a)   Public Announcement or Release.

On January 12, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary financial results for the fiscal quarter and year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The preliminary financial results included in the press release are based on the Company’s current estimate of its results for the fiscal quarter and year ended December 31, 2025, and remain subject to change based on the completion of closing and review procedures.

The information contained in this Item 2.02 of the Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d)   Exhibits.

	Exhibit No.		Description
	99.1		Press Release, dated January 12, 2026
	104		Cover Page Interactive Data File (embedded within the inline XBRL document)

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	KORU Medical Systems, Inc. (Registrant)
Date:  January 12, 2026	By:	/s/ Linda Tharby
		Linda Tharby President and Chief Executive Officer

- 3 -

FAQ

What did KORU Medical Systems (KRMD) disclose in this 8-K?

KORU Medical Systems disclosed that it issued a press release announcing certain preliminary financial results for the fiscal quarter and year ended December 31, 2025, furnished as Exhibit 99.1.

Which period do KORU Medical Systems' preliminary results cover?

The preliminary financial results relate to the fiscal quarter and full fiscal year ended December 31, 2025.

Are KORU Medical Systems' preliminary 2025 results final?

No. The company states that the preliminary results are based on current estimates and remain subject to change after completion of closing and review procedures.

Where can investors find detailed preliminary numbers for KORU Medical Systems (KRMD)?

The detailed preliminary financial information is contained in the press release that is furnished as Exhibit 99.1 to this report.

How is the preliminary financial information treated under securities laws?

The company notes that the information in this report is being furnished, not filed, under the Exchange Act and is not subject to Section 18 liabilities or automatically incorporated into other filings unless specifically referenced.